Relmada Therapeutics, Inc. (RLMD)
2.62
-0.49
(-15.76%)
USD |
NASDAQ |
Nov 20, 16:00
2.615
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Research and Development Expense (TTM) : 33.77M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 33.77M |
| June 30, 2026 | 28.59M |
| March 31, 2026 | 23.02M |
| December 31, 2025 | 26.88M |
| September 30, 2025 | 29.81M |
| June 30, 2025 | 36.92M |
| March 31, 2025 | 44.82M |
| December 31, 2024 | 46.18M |
| September 30, 2024 | 49.93M |
| June 30, 2024 | 49.23M |
| March 31, 2024 | 52.25M |
| December 31, 2023 | 54.81M |
| September 30, 2023 | 66.92M |
| June 30, 2023 | 87.00M |
| March 31, 2023 | 104.17M |
| December 31, 2022 | 113.32M |
| September 30, 2022 | 111.73M |
| June 30, 2022 | 115.19M |
| March 31, 2022 | 101.61M |
| December 31, 2021 | 90.62M |
| September 30, 2021 | 80.25M |
| June 30, 2021 | 57.49M |
| Date | Value |
|---|---|
| March 31, 2021 | 45.49M |
| December 31, 2020 | 35.97M |
| September 30, 2020 | 24.14M |
| June 30, 2020 | 14.18M |
| March 31, 2020 | 10.11M |
| June 30, 2019 | 7.025M |
| March 31, 2019 | 4.914M |
| December 31, 2018 | 5.305M |
| September 30, 2018 | 4.198M |
| June 30, 2018 | 2.943M |
| March 31, 2018 | 2.168M |
| December 31, 2017 | 0.9917M |
| September 30, 2017 | 1.095M |
| June 30, 2017 | 1.294M |
| March 31, 2017 | 1.723M |
| December 31, 2016 | 1.841M |
| September 30, 2016 | 3.705M |
| June 30, 2016 | 6.207M |
| March 31, 2016 | 8.458M |
| December 31, 2015 | 10.12M |
| September 30, 2015 | 10.10M |
| June 30, 2015 | 7.95M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Talphera, Inc. | 7.09M |
| Journey Medical Corp. | 0.259M |
| ANI Pharmaceuticals, Inc. | 50.60M |
| Corcept Therapeutics, Inc. | 241.72M |
| Veru, Inc. | 11.76M |